Recombinant Mouse Glucose-6-phosphate isomerase Protein，His

Glucose-6-phosphate isomerase (GPI), also known as phosphoglucose isomerase, is an enzyme that plays a crucial role in the glycolytic and gluconeogenic pathways by catalyzing the reversible conversion of glucose-6-phosphate to fructose-6-phosphate. This enzyme not only participates in carbohydrate metabolism but also has functions beyond metabolism, including involvement in cellular signaling, tumor progression, and inflammation. Its significance in health and disease has driven the demand for detailed studies of its structure and function. Recombinant GPI proteins are essential for investigating its biochemical properties, understanding its regulatory mechanisms, and exploring its potential as a therapeutic target. Advances in molecular cloning and expression techniques have facilitated the production of high-purity recombinant GPI, allowing for extensive biochemical characterization, including enzymatic activity assays, structural studies via X-ray crystallography, and binding affinity analyses. Research into GPI also extends to its role in various diseases, such as cancer, where altered GPI expression may influence tumor growth and metastasis. Consequently, recombinant GPI is not only a valuable tool for fundamental research in enzymology and metabolic pathways but also a promising avenue for developing targeted therapies, making its study highly relevant in both basic and applied life sciences.